RxDoctor Payments Data

Chad Peterson, DO

MOHS-Micrographic Surgery · Spanish Fork, UTNPI 1821299751

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 95.3% of the total across 339 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 14.1% — the pattern of someone who eats at a lot of different presentations.

$6,403in general payments, 2019–2025

Across 339 payments — averaging $18.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$902
  • Johnson & Johnson$655
  • Sun Pharmaceutical Industries Inc.$621
  • UCB, Inc.$580
  • Pfizer$565
  • Novartis$492
  • plus $3K from 20 others
$6,632in research payments, 2019–2025

Across 7 payments — averaging $947.43 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AbbVie$7K

What the payments were for

  • Food & beverage$6,10495%
  • Education$2995%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

Too few mohs-micrographic surgery providers in Utahto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$456,710
Medicare patients
509
Services billed
4,083

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Betamethasone Dipropionate63$2,412
Fluorouracil26$1,711
Clobetasol Propionate24$1,211
Cephalexin201$971
Minocycline Hcl36$962
Triamcinolone Acetonide59$760
Doxycycline Hyclate15$704
MethotrexateMethotrexate Sodium16$455
Doxycycline Monohydrate15$261
Terbinafine Hcl20$217
Mupirocin25$212
Fluconazole14$119
Ibuprofen12$41

Paid to pharmacies, not to this prescriber.

Other mohs-micrographic surgery in Spanish Fork

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →